Unknown

Dataset Information

0

Deregulated Syk inhibits differentiation and induces growth factor-independent proliferation of pre-B cells.


ABSTRACT: The nonreceptor protein spleen tyrosine kinase (Syk) is a key mediator of signal transduction in a variety of cell types, including B lymphocytes. We show that deregulated Syk activity allows growth factor-independent proliferation and transforms bone marrow-derived pre-B cells that are then able to induce leukemia in mice. Syk-transformed pre-B cells show a characteristic pattern of tyrosine phosphorylation, increased c-Myc expression, and defective differentiation. Treatment of Syk-transformed pre-B cells with a novel Syk-specific inhibitor (R406) reduces tyrosine phosphorylation and c-Myc expression. In addition, R406 treatment removes the developmental block and allows the differentiation of the Syk-transformed pre-B cells into immature B cells. Because R406 treatment also prevents the proliferation of c-Myc-transformed pre-B cells, our data indicate that endogenous Syk kinase activity may be required for the survival of pre-B cells transformed by other oncogenes. Collectively, our data suggest that Syk is a protooncogene involved in the transformation of lymphocytes, thus making Syk a potential target for the treatment of leukemia.

SUBMITTER: Wossning T 

PROVIDER: S-EPMC2118175 | biostudies-literature | 2006 Dec

REPOSITORIES: biostudies-literature

altmetric image

Publications

Deregulated Syk inhibits differentiation and induces growth factor-independent proliferation of pre-B cells.

Wossning Thomas T   Herzog Sebastian S   Köhler Fabian F   Meixlsperger Sonja S   Kulathu Yogesh Y   Mittler Gerhard G   Abe Akihiro A   Fuchs Uta U   Borkhardt Arndt A   Jumaa Hassan H  

The Journal of experimental medicine 20061127 13


The nonreceptor protein spleen tyrosine kinase (Syk) is a key mediator of signal transduction in a variety of cell types, including B lymphocytes. We show that deregulated Syk activity allows growth factor-independent proliferation and transforms bone marrow-derived pre-B cells that are then able to induce leukemia in mice. Syk-transformed pre-B cells show a characteristic pattern of tyrosine phosphorylation, increased c-Myc expression, and defective differentiation. Treatment of Syk-transformed  ...[more]

Similar Datasets

| S-EPMC3419062 | biostudies-literature
| S-EPMC8199440 | biostudies-literature
| S-EPMC3469064 | biostudies-literature
| S-EPMC3943792 | biostudies-literature
| S-EPMC9311789 | biostudies-literature
| S-EPMC539153 | biostudies-other
| S-EPMC10103476 | biostudies-literature
| S-EPMC4130781 | biostudies-literature
| S-EPMC6627659 | biostudies-literature
| S-EPMC2766237 | biostudies-literature